Briquilimab
JSP-CP-012
Phase 1 small_molecule terminated
Quick answer
Briquilimab for Allergic Asthma is a Phase 1 program (small_molecule) at Jasper Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jasper Therapeutics
- Indication
- Allergic Asthma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated